Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Net Preferred Shares Issued and Repurchased (2015 - 2020)

Updated

Outlook Therapeutics (OTLK) reported Net Preferred Shares Issued and Repurchased of $21.74 million for FY2018 (year ended Sep 30, 2018), up 566.2% from $3.26 million in FY2017.

Analysis

Outlook Therapeutics (OTLK) Net Preferred Shares Issued and Repurchased (2015 - 2020) Analysis & Trends

  • According to Business Quant data, Net Preferred Shares Issued and Repurchased came in at $3.26 million in FY2017 and -$226,001 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 10.33 Mn
Mar 31, 2019 -61,365.00
Mar 31, 2018 -381,664.00
Dec 31, 2017 21.74 Mn
Sep 30, 2015 627,001.00
API Access

Outlook Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=OTLK&period=max&api_key=YOUR_API_KEY